Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation.
Accurso FJ; Rowe SM; Clancy JP; Boyle MP; Dunitz JM; Durie PR; Sagel SD; Hornick DB; Konstan MW; Donaldson SH; Moss RB; Pilewski JM; Rubenstein RC; Uluer AZ; Aitken ML; Freedman SD; Rose LM; Mayer-Hamblett N; Dong Q; Zha J; Stone AJ; Olson ER; Ordoñez CL; Campbell PW; Ashlock MA; Ramsey BW; The New England Journal Of Medicine, 2010, vol. 363, issue 21, p 1991, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation